Search For "subject"
SEC asks for more data to grant full market approval to Covaxin and Covish
Updated : 4 years, 2 months ago IST
New Delhi [India], January 14 (ANI): The Drugs Controller General of India's (DCGI) Subject Expert Committee (SEC) will continue thorough review of data submitted by the Serum Institute of India (SII) and Bharat Biotech for granting full market approval to Covaxin and Covishield, sources
Read More
DCGI's SEC to review applications of Bharat Biotech, SII for full market a
Updated : 4 years, 2 months ago IST
New Delhi [India], January 14 (ANI): Drugs Controller General of India (DCGI)'s Subject Expert Committee will review applications of Bharat Biotech and Serum Institute of India (SII) for full market approval to Covaxin and Covishield respectively on Friday, sources said.
Read More
Study finds youngsters who self-identify as multilingual perform better at
Updated : 4 years, 2 months ago IST
Cambridge [UK], January 13 (ANI): A new research has found that young adults who consider themselves multilingual tend to perform better across a wide range of subjects at school, regardless of whether they are actually fluent in another language.
Read More
ISL: East Bengal rope in young Brazilian striker Marcelo on loan
Updated : 4 years, 2 months ago IST
Panaji (Goa) [India], January 10 (ANI): SC East Bengal on Monday announced the signing of young Brazilian striker Marcelo Ribeiro dos Santos on loan from Gil Vicente FC till the end of the season subject to clearances.
Read More
Mapping of subject-wise teachers for schools should be taken as top priori
Updated : 4 years, 2 months ago IST
Amravati (Andhra Pradesh) [India], January 6 (ANI): Andhra Pradesh Chief Minister YS Jagan Mohan Reddy chaired a review meeting with the education department and said mapping of subject-wise teachers for schools should be taken as a top priority.
Read More
Bharat Biotech gets SEC approval for phase 3 clinical trials of COVID boos
Updated : 4 years, 2 months ago IST
New Delhi [India], January 5 (ANI): The Subject Experts Committee (SEC) of the Drug Controller General of India (DCGI) on Wednesday granted approval to Bharat Biotech for conducting intranasal phase 3 trials and heterologous trials for COVID-19 booster intranasal vaccine for those who hav
Read More
ICSE Semester 2 Exams to be expected in March: Important Time Management T
Updated : 4 years, 2 months ago IST
New Delhi [India], January 4 (ANI/Oswaal Books): ICSE semester 2 Board Exams 2022 will be conducted in March or April 2022. The exams will most probably be conducted in a subjective format.
Read More
SEC to hold meeting on Bharat Biotech's Nasal vaccine booster dose
Updated : 4 years, 2 months ago IST
New Delhi [India], January 4 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is expected to meet on Tuesday afternoon to discuss Bharat Biotech's application for clinical trials of its intranasal Covid vaccine as a booster or a third dose.
Read More
BJP holds Chief Ministers' Council meeting to review governance, implement
Updated : 4 years, 2 months ago IST
New Delhi [India], January 4 (ANI): Bharatiya Janata Party (BJP) on Monday held a meeting of the Chief Ministers' Council at party headquarters in the national capital to review governance and implementation of welfare schemes based on 28 subjects emphasized by Prime Minister Narendra Modi.
Read More
Health state subject, State Govts free to take decision: Civil Aviation Mi
Updated : 4 years, 2 months ago IST
New Delhi [India], December 30 (ANI): Following West Bengal's decision of suspending flights from the UK, a Civil Aviation Ministry official said that health is a state subject and they are free to take decisions as per the Centre's COVID guidelines.
Read More
SEC recommends emergency use authorization of Covovax, Corbevax vaccines f
Updated : 4 years, 2 months ago IST
New Delhi [India], December 28 (ANI): After reviewing all applications and data, the Subject Expert Committee (SEC), a body under India's drug regulator, has recommended granting the Emergency Use Authorization (EUA) to Serum Institute of India's COVID-19 vaccine Covovax and Corbevax vacc
Read More
SEC to take decision on antiviral Covid pill today
Updated : 4 years, 2 months ago IST
New Delhi [India], December 27 (ANI): After reviewing all applications and data on antiviral pills, the Subject expert committee (SEC) a body under India's drug regulator will be meeting today for antiviral pill Molnupiravir recommendations, sources told to ANI.
Read More